Stocktoria
Indaptus Therapeutics, Inc. INDP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-09-07
Indaptus Therapeutics, Inc. statistics & valuation
Market cap$386.2M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -223.9% | -204.7% | -103.3% | -51.0% | -19.0% |
| Return on equity | -661.5% | -380.8% | -127.7% | -58.2% | -21.5% |
| Current ratio | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 |
Source: SEC EDGAR filings · CIK 0001857044 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.